CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

CATXPerspective Therapeutics, Inc.

AMEX · PHARMACEUTICAL PREPARATIONS
Last close $2.75 · 2026-09-30
ABOUT
ExchangeAMEX
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$313.92M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-08 · Lantheus Alpha Therapy, LLC (10% Owner) · SELL
  • 2026-09-04 · Lantheus Alpha Therapy, LLC (10% Owner) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders144
Shares held96,818,478
Value$358.03M
Percent of shares outstanding84.82%
As of quarter end2026-06-30
RECENT NEWS
  • Perspective Therapeutics wins FDA Fast Track designation for PSV359
  • Perspective Therapeutics' [212Pb]VMT-α-NET data accepted for NANETS 2026 presentation
  • Perspective Therapeutics' [212Pb]VMT01 data accepted for SITC 2026 presentation
  • Perspective Therapeutics partners with Merck to study PSV359 with Keytruda in solid tumors
  • Perspective Therapeutics, Inc. · 8-K (8.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Perspective Therapeutics, Inc. (CATX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit